- Optos, the Scottish retinal imaging pioneer, develops world-leading technology that helps clinicians detect eye disease early and prevent sight loss for thousands of patients globally.
- As the company expands internationally, Optos requires resilient, consistent connectivity to keep mission-critical teams aligned.
- Vodafone Business SD-WAN now provides Optos with a unified, simplified global network that is easier to manage and scale.
Vodafone Business has signed a three-year agreement to implement a global Software-Defined Wide Area Network (SD-WAN) for Optos, the Scottish retinal imaging technology company whose innovations help protect the sight of millions worldwide. The SD-WAN solution will replace a patchwork of legacy systems, giving Optos a consolidated, highly reliable network to support its continued global growth.
Powered by Vodafone Business SD-WAN, Optos now benefits from real-time visibility and centralised control across its entire network estate. This allows IT teams to optimise performance between sites worldwide while reducing complexity by managing everything through one unified platform.
With stable, secure and resilient connectivity now in place, Optos can streamline communication between departments, avoid costly downtime, and focus investment on research, innovation and scaling the business.
Adam Shaw, Head of IT at Optos, said:
“Working with Vodafone Business has been transformative for Optos. Their SD-WAN solution gives us the secure, resilient connectivity we need to link our global sites and allows us to grow without constantly purchasing new technology – it grows with us. This collaboration ensures we can provide clinicians with the tools they need to continue their work to help protect vision for millions worldwide.”
Vodafone Business has been working with Optos since 2019 and already provides mobile connectivity.
Find out more about Vodafone Business’ SD WAN solution here: Software Defined Networking (SDN) for Business | Vodafone UK
About Optos
When a five-year-old boy lost his sight in one eye after a regular eye exam failed to spot a retinal detachment, his father made it his life’s work to help eye care professionals by revolutionizing retinal imaging. Optos was founded by Douglas Anderson to make a patient-friendly device to capture a digital ultra-widefield image of the retina. Today, millions of patients around the world have benefited from optomap® retinal imaging in approximately 30,000 locations.
Our products produce high-resolution optomap images of 82% or 200◦ of the retina, something no other imaging device is capable of in a single capture. In addition, our latest devices, MonacoPro Spectral Domain OCT and SilverstoneRGB Swept Source OCT, integrate ultra-widefield retinal imaging and image-guided Optical Coherence Tomography (OCT). All devices facilitate the early detection, management, and effective treatment of disorders and diseases evidenced in the retina, such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. More than 4,000 published and ongoing clinical trials, as well as thousands of case studies and testimonials, show the long-term value of optomap imaging and OCT in diagnosis, treatment planning, and patient engagement.
As a division of Nikon Co. Ltd, Japan, since 2015 Optos is proud to be recognized as a leading provider of devices to eye care professionals to provide a more complete approach to patient care.
Be First to Comment